Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease
- 30 March 2026
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 63 (11) , 1565-1566
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's DiseaseAlimentary Pharmacology & Therapeutics, 2026
- Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy alone for Crohn's perianal fistulas (PISA-II): long-term outcomes of an international, multicentre patient preference, randomised controlled trialeClinicalMedicine, 2023
- Epidemiology and Natural History of Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis of Population-Based CohortsInflammatory Bowel Diseases, 2021